GeoVax and Emory University to Collaborate on HPV Therapeutic Program for Head and Neck Cancers
30 juil. 2018 09h00 HE
|
GeoVax, Inc.
GeoVax Continues Expansion of its MVA-VLP Vaccine Pipeline with Multiple Collaborations in Infectious Disease and Immuno-oncology ATLANTA, GA, July 30, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc....
GeoVax to Present at the American Society for Virology 2018 Annual Meeting
09 juil. 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, July 09, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” at the Vaccine Industry Excellence (ViE) Awards during the World Vaccine Congress,...
GeoVax Awarded NIH Grant for Novel Zika Vaccine
24 mai 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, , May 24, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that the National Institute of Allergy and...
GeoVax Reports 2018 First Quarter Financial Results and Development Program Updates
03 mai 2018 13h00 HE
|
GeoVax, Inc.
ATLANTA, May 03, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB:GOVX), a biotechnology company developing human vaccines, today announced its financial results for the three months ended March...
GeoVax Recognized as “Best Biotech” at Vaccine Industry Excellence Awards during World Vaccine Congress
05 avr. 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, April 05, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, is honored to announce that it won “Best Biotech” at the World...
GeoVax to Present at the 2018 ASM Biothreats Conference
31 janv. 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, Jan. 31, 2018 (GLOBE NEWSWIRE) --
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced that its Chief Scientific Officer, Farshad...
GeoVax to Collaborate with the U.S. Naval Research Laboratory On Development of Lassa Fever Biosensors
12 déc. 2017 09h00 HE
|
GeoVax, Inc.
Atlanta, GA, Dec. 12, 2017 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with the U.S. Naval...